Get informed when a big investor buys or sells
+ FollowOvervalued by 137.5% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $2.32 Million |
|---|---|
| Enterprise Value | $3.78 Million |
| Earnings per Share | $0 |
| Beta | 0.67 |
| Outstanding Shares | 966,942,572 |
| P/E Ratio | -75.79 |
|---|---|
| PEG | 35.52 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 21.28 |
| Enterprise Value to EBIT | -334.66 |
| Enterprise Value to Net Income | -124 |
| Total Debt to Enterprise | 0.39 |
| Debt to Equity | 12.29 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
AVVAA World Health Care Products, Inc. operates as a global biotechnology firm, specializing in natural and therapeutic personal care solutions. Its primary endeavor involves the development, manufacturing, and mass-market distribution o...